Citations 1
Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).
Bernath, Albert M., Northfelt, Donald W. , Hou, Xiaonan , Tenner, Kathleen , Tienchaiananda, Piyawan , Flickinger, Lynn M. , Chen, Beiyun, Chen, Helen X., Lingle, Wilma L., Pellegrino, Christine, Sponzo, Robert W., Reinholz, Monica M., Perez, Edith A. , Haluska, Paul , Ballman, Karla V. , Dueck, Amylou C. , Linden, Hannah M. , Goetz, Matthew P.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 632-632
